Skip to content
Screener

Net margin at other companies

Eli Lilly logo
Eli LillyLLY
33.5%+7.6pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
21.5%-3.5pp
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-8.9%-20.5pp
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-26.6%-9.8pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-3,658.5%-1,388pp

Other financials

Income statement

See full
Revenue-
Operating income-$123.2M-30.7%
Net income-$110.7M-30.7%
EPS (diluted)-$1.11-3.7%

Balance sheet

See full
Cash & equivalents$119.5M-11.7%
Total debt$6.4M-26.4%
Total equity$1.2B+96.0%
Total assets$1.3B+92.2%

Cash flow

See full
Operating cash flow-$95.4M-48.5%
CapEx$275.0K+75.2%
Free cash flow-$95.7M-48.6%

Valuation

See full
Market cap$6.24B+137%
Enterprise value$6.13B+145%

Profitability

See full
Operating margin-4,974.3%
FCF margin-3,732.2%

Returns & leverage

See full
Return on equity-43.6%+8.2pp
Debt / equity0.0×
Current ratio21×+5.9×

Where this comes from

Calculated from Xenon Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:31 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338244

FAQ

What is Xenon Pharmaceuticals's net margin?
Xenon Pharmaceuticals (XENE) reported net margin of -4,612.1% in Q4 2025.
What is the long-term trend for Xenon Pharmaceuticals's net margin?
Over 3 years (2020 to 2025), Xenon Pharmaceuticals's net margin has grown at a 271.9% compound annual growth rate (CAGR), from -89.7% to -4,612.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Xenon Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude